Kyowa Kirin Co Eulerpool News

Kyowa Kirin Co Aktie News

Kyowa Kirin Co wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Kyowa Kirin Co News stellen wir hier zusammen.

• 12. Juni ·

  Yahoo
  Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
• 22. Mai ·

  Yahoo
  Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
• 23. Januar ·

  SeekingAlpha
  Kura Oncology: Sentiment Is Too Negative
• 9. Dezember ·

  Yahoo
  Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
• 24. November ·

  SeekingAlpha
  BridgeBio: Next Chapter Begins After Attruby Approval
• 20. November ·

  Yahoo
  Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
• 31. Oktober ·

  Yahoo
  Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
• 25. September ·

  Yahoo
  Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis
• 23. August ·

  Yahoo
  Kyowa Kirin to end distribution of Fareston (toremefine) in the United States
• 11. August ·

  SeekingAlpha
  Week In Review: Curon Out-Licenses T-Cell-Engager To Merck For $700 Million Upfront